Related Experiment Video
Updated: Jul 30, 2026

Sampling Blood from the Lateral Tail Vein of the Rat
Published on: May 18, 2015
[Changes in blood coagulation in stress and depression--from evolution to gene regulation]
1Institut für Verhaltenswissenschaft, Eidgenössische Technische Hochschule Zürich. roland.vonkaenel@ifv.gess.ethz.ch
Insights
Mental stress and depression can lead to blood hypercoagulability, increasing heart disease risk. Interventions like beta-blockers and SSRIs may help manage this risk by affecting coagulation and platelet activity.
Area of Science:
- Cardiovascular Science
- Neuroscience
- Hematology
Context:
- Mental stress and depression are linked to a hypercoagulable state.
- This state may contribute to increased cardiovascular risk in affected individuals.
- The sympathetic nervous system, via catecholamines and adrenergic receptors, largely mediates these coagulation changes.
Purpose:
- To explore the relationship between mental stress, depression, and blood coagulation.
- To investigate the mechanisms underlying stress-induced hypercoagulability.
- To examine the potential of therapeutic interventions in mitigating these risks.
Summary:
- Stress and depression induce a hypercoagulable state, potentially increasing coronary risk.
- Sympathetic nervous system activity and gene regulation influence coagulation and fibrinolysis.
- Non-selective beta-blockers and selective serotonin reuptake inhibitors show promise in managing hypercoagulability.
Impact:
- Highlights the link between mental health and cardiovascular health through coagulation pathways.
- Suggests potential therapeutic targets for reducing cardiovascular risk in stressed or depressed populations.
- Emphasizes the need for prospective studies to confirm the association with hard cardiovascular endpoints and treatment efficacy.
Abstract:
Mental stress and depression are characterized by a hypercoagulable state, which might mediate the increased coronary risk in individuals who feel stressed or depressed. Changes in blood coagulation and fibrinolysis with stress and depression are largely mediated by the sympathetic nervous system via catecholamine and adrenergic receptor activity. Stress might also affect coagulation activity via an influence on the regulation of genes coding for coagulation and fibrinolysis molecules. There is some evidence that non-selective beta-blocking agents decrease hypercoagulability elicited by acute stress. The selective serotonin reuptake inhibitors appear to normalize increased platelet activity in depression. Prospective studies need to show whether there is an association between coagulation abnormalities in stress and depression with hard cardiovascular end-points and whether such an association is favorably affected by therapeutic interventions (e.g., medication, psychotherapy, stress management).
More Related Videos
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Introduction to Stress and Lifestyle
Physiological Foundation of Stress
Role of the Sympathetic Nervous System
Adrenaline triggers the...
Stress and Mental Health
Individuals with depression often experience challenges in both their personal and professional...

